EVALUATION OF MULTIPLE BIOLOGIC PARAMETERS IN CERVICAL-CARCINOMA - HIGH MACROPHAGE INFILTRATION IN HPV-ASSOCIATED TUMORS

被引:18
作者
CONNOR, ME
DAVIDSON, SE
STERN, PL
ARRAND, JR
WEST, CML
机构
[1] CHRISTIE HOSP,NHS TRUST,PATERSON INST CANC,CANC RES CAMPAIGN DEPT EXPTL RADIAT ONCOL,WILMSLOW RD,MANCHESTER M20 9BX,ENGLAND
[2] CHRISTIE HOSP,NHS TRUST,PATERSON INST CANC,CANC RES CAMPAIGN DEPT IMMUNOL,MANCHESTER M20 9BX,ENGLAND
[3] CHRISTIE HOSP,NHS TRUST,PATERSON INST CANC RES,DEPT MOLEC BIOL,MANCHESTER M20 9BX,ENGLAND
关键词
CERVICAL CARCINOMA; COLONY-FORMING EFFICIENCY; HPV; MACROPHAGE; MHC; RADIOSENSITIVITY;
D O I
10.1046/j.1525-1438.1993.03020103.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of diverse biologic parameters have been assessed prior to treatment in a series of patients with cervical carcinoma. Factors analyzed were HPV DNA presence, MHC class I expression, expression of the oncofetal antigen 5T4, the proportions of macrophages, lymphocytes and granulocytes in cell suspensions prepared from tumors, in vitro colony-forming efficiency (CFE) and a measure of intrinsic radiosensitivity, surviving fraction at 2 Gy. Several associations were found. First, HPV DNA-negative tumors contained a small, but significant, decreased number of tumor infiltrating macrophages compared with HPV DNA-positive tumors. Secondly, patients with HPV-positive tumors were significantly younger than those where no HPV was detected. Thirdly, loss of one or more specific alleles in MHC class I positive tumors resulted in higher numbers of tumor lymphocytes and CFEs. Finally, strong expression of the 5T4 antigen was related to a reduction in the proportion of macrophages in tumor cell suspensions. In addition, for stage I and II patients expression of the MHC class I molecule was associated with improved survival compared with patients with tumors where loss of expression was seen.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 32 条
[1]   POSSIBLE PROGNOSTIC-SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS TYPE IN CERVICAL-CANCER [J].
BARNES, W ;
DELGADO, G ;
KURMAN, RJ ;
PETRILLI, ES ;
SMITH, DM ;
AHMED, S ;
LORINCZ, AT ;
TEMPLE, GF ;
JENSON, AB ;
LANCASTER, WD .
GYNECOLOGIC ONCOLOGY, 1988, 29 (03) :267-273
[2]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[3]   A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER [J].
BOSHART, M ;
GISSMANN, L ;
IKENBERG, H ;
KLEINHEINZ, A ;
SCHEURLEN, W ;
HAUSEN, HZ .
EMBO JOURNAL, 1984, 3 (05) :1151-1157
[4]   LOSS OF MHC CLASS-I EXPRESSION IN CERVICAL CARCINOMAS [J].
CONNOR, ME ;
STERN, PL .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (06) :1029-1034
[5]   LACK OF ASSOCIATION BETWEEN INVITRO CLONOGENIC GROWTH OF HUMAN CERVICAL-CARCINOMA AND TUMOR STAGE, DIFFERENTIATION, PATIENT AGE, HOST-CELL INFILTRATION OR PATIENT SURVIVAL [J].
DAVIDSON, SE ;
WEST, CML ;
HUNTER, RD .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (01) :10-14
[6]   MARKEDLY DECREASED EXPRESSION OF CLASS-I HISTOCOMPATIBILITY ANTIGENS, PROTEIN, AND MESSENGER-RNA IN HUMAN SMALL-CELL LUNG-CANCER [J].
DOYLE, A ;
MARTIN, WJ ;
FUNA, K ;
GAZDAR, A ;
CARNEY, D ;
MARTIN, SE ;
LINNOILA, I ;
CUTTITTA, F ;
MULSHINE, J ;
BUNN, P ;
MINNA, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1135-1151
[7]  
DURST M, 1983, P NATL ACAD SCI USA, V80, P3312
[8]   EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS AND CHARACTERIZATION OF MONONUCLEAR CELL INFILTRATES IN HUMAN RENAL-CELL CARCINOMAS [J].
HEINEMANN, D ;
SMITH, PJB ;
SYMES, MO .
BRITISH JOURNAL OF CANCER, 1987, 56 (04) :433-437
[9]   THE PROPORTION OF STEM-CELLS IN MURINE TUMORS [J].
HILL, RP ;
MILAS, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (02) :513-518
[10]   A 72KD TROPHOBLAST GLYCOPROTEIN DEFINED BY A MONOCLONAL-ANTIBODY [J].
HOLE, N ;
STERN, PL .
BRITISH JOURNAL OF CANCER, 1988, 57 (03) :239-246